EVP, Global Head of Strategy, dentsu health
Kent is the global strategy lead for dentsu health. Prior to assuming this role, Kent had been the head of health strategy for Merkle, a dentsu international company, for 11 years. He has been consulting in the areas of pharmaceutical, provider and payer CXM for more than 20 years. In addition to broad blog/whitepaper and conference activity, he is a recognized global SME in physician prescribing behavior, and is published extensively in a variety of journals and mainstream publications including, Research in Social and Administrative Pharmacy, Formulary, the Journal of Clinical Pharmacy and Therapeutics, British Medical Journal, Pharmaceutical Executive, Medical Marketing and Media and PM360.
Kent has worked with a number of clients across multiple therapeutic areas in the pharmaceutical, healthcare, and animal health vertical including AbbVie, AstraZeneca, BMS, Boehringer Ingelheim, Sanofi (Genzyme, Chattem and Merial), and Seattle Genetics focusing on engagement, communication and CXM strategy in the US, Canada, Europe and Australasia. He is passionate about digital advancement of personal wellness and enhancing patient/customer/HCP engagement and health outcomes.
He has a PhD in Pharmaceutical Strategy and Policy from Dalhousie University in Halifax, NS, and holds the position of Assistant Professor, Clinical Pharmacy, at the James L Winkle College of Pharmacy, University of Cincinnati.